Psychosocial Risk Factors for Alzheimer’s Disease in Patients with Down Syndrome and Their Association with Brain Changes: A Narrative Review

被引:0
|
作者
Osama Hamadelseed
Ibrahim H. Elkhidir
Thomas Skutella
机构
[1] University of Heidelberg,Department of Neuroanatomy, Institute of Anatomy and Cell Biology
[2] University of Khartoum,Faculty of Medicine
来源
Neurology and Therapy | 2022年 / 11卷
关键词
Alzheimer’s disease; Corpus callosum; Dementia; Down syndrome; Hippocampus; Psychosocial risk factors;
D O I
暂无
中图分类号
学科分类号
摘要
Several recent epidemiological studies attempted to identify risk factors for Alzheimer’s disease. Age, family history, genetic factors (APOE genotype, trisomy 21), physical activity, and a low level of schooling are significant risk factors. In this review, we summarize the known psychosocial risk factors for the development of Alzheimer’s disease in patients with Down syndrome and their association with neuroanatomical changes in the brains of people with Down syndrome. We completed a comprehensive review of the literature on PubMed, Google Scholar, and Web of Science about psychosocial risk factors for Alzheimer’s disease, for Alzheimer’s disease in Down syndrome, and Alzheimer’s disease in Down syndrome and their association with neuroanatomical changes in the brains of people with Down syndrome. Alzheimer’s disease causes early pathological changes in individuals with Down syndrome, especially in the hippocampus and corpus callosum. People with Down syndrome living with dementia showed reduced volumes of brain areas affected by Alzheimer’s disease as the hippocampus and corpus callosum in association with cognitive decline. These changes occur with increasing age, and the presence or absence of psychosocial risk factors impacts the degree of cognitive function. Correlating Alzheimer’s disease biomarkers in Down syndrome and cognitive function scores while considering the effect of psychosocial risk factors helps us identify the mechanisms leading to Alzheimer’s disease at an early age. Also, this approach enables us to create more sensitive and relevant clinical, memory, and reasoning assessments for people with Down syndrome.
引用
收藏
页码:931 / 953
页数:22
相关论文
共 50 条
  • [31] Iron accumulation/overload and Alzheimer's disease risk factors in the precuneus region: A comprehensive narrative review
    Mohammadi, Sana
    Ghaderi, Sadegh
    Fatehi, Farzad
    AGING MEDICINE, 2024, 7 (05) : 649 - 667
  • [32] Microvascular changes in Down syndrome with Alzheimer's-type pathology: Insights into a potential vascular mechanism for Down syndrome and Alzheimer's disease
    Drachman, David A.
    Smith, Thomas W.
    Alkamachi, Bassam
    Kane, Kevin
    ALZHEIMERS & DEMENTIA, 2017, 13 (12) : 1389 - 1396
  • [33] Heat-shock protein 70 levels in brain of patients with Down Syndrome and Alzheimer's disease
    Yoo, BC
    Seidl, R
    Cairns, N
    Lubec, G
    JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT, 1999, (57): : 315 - 322
  • [34] Hypersynchronized Magnetoencephalography Brain Networks in Patients with Mild Cognitive Impairment and Alzheimer's Disease in Down Syndrome
    Ramirez-Torano, Federico
    Garcia-Alba, Javier
    Bruna, Ricardo
    Esteba-Castillo, Susanna
    Vaquero, Lucia
    Pereda, Ernesto
    Maestu, Fernando
    Fernandez, Alberto
    BRAIN CONNECTIVITY, 2021, 11 (09) : 725 - 733
  • [35] Decreased levels of synaptosomal associated protein 25 in the brain of patients with Down Syndrome and Alzheimer's disease
    Greber, S
    Lubec, G
    Cairns, N
    Fountoulakis, M
    ELECTROPHORESIS, 1999, 20 (4-5) : 928 - 934
  • [36] Decreased brain histamine-releasing factor protein in patients with Down syndrome and Alzheimer's disease
    Kim, SH
    Cairns, N
    Fountoulakisc, M
    Lubec, G
    NEUROSCIENCE LETTERS, 2001, 300 (01) : 41 - 44
  • [37] Regional Brain Metabolism across the Alzheimer's Disease Continuum in Down Syndrome
    Arriola-Infante, Jose Enrique
    Morcillo-Nieto, Alejandra O.
    Zsadanyi, Sara E.
    Franquesa-Mullerat, Maria
    Vaque-Alcazar, Lidia
    Rozalem-Aranha, Mateus
    Arranz, Javier
    Rodriguez-Baz, Inigo
    Maure-Blesa, Lucia
    Videla, Laura
    Barroeta, Isabel
    Soriano, Laura Del Hoyo
    Benejam, Bessy
    Fernandez, Susana
    Sanjuan-Hernandez, Aida
    Gimenez, Sandra
    Alcolea, Daniel
    Belbin, Olivia
    Flotats, Albert
    Camacho, Valle
    Lleo, Alberto
    Carmona-Iragui, Maria
    Fortea, Juan
    Bejanin, Alexandre
    ANNALS OF NEUROLOGY, 2025,
  • [38] Decoding brain structure to stage Alzheimer's disease pathology in Down syndrome
    Kennedy, James T.
    Wisch, Julie K.
    Dincer, Aylin
    Roman, June
    Gordon, Brian A.
    Handen, Benjamin
    Benzinger, Tammie L. S.
    Head, Elizabeth
    Mapstone, Mark
    Christian, Bradley T.
    Tudorascu, Dana L.
    Laymon, Charles L.
    Hartley, Sigan L.
    Lao, Patrick
    Brickman, Adam M.
    Zaman, Shahid H.
    Ances, Beau M.
    ALZHEIMERS & DEMENTIA, 2025, 21 (02)
  • [39] Risk factors for agitation in patients with Alzheimer's disease
    Auchus, AP
    Woodard, JL
    Simpson, SR
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1996, 44 (09) : P192 - P192
  • [40] Association of periodontitis and oral microbiomes with Alzheimer's disease: A narrative systematic review
    Mao, Samantha
    Huang, Chen-Pang
    Lan, Hsin
    Lau, Hing-Ger
    Chiang, Chun-Pin
    Chen, Yi-Wen
    JOURNAL OF DENTAL SCIENCES, 2022, 17 (04) : 1762 - 1779